MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT

MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT

A subset of AML patients are unfit for 7+3 induction at the time of diagnosis. Present case highlights the use of azacitidine and venetoclax in a patient with intermediate risk AML with WT-1 mutation,deemed unfit for intensive induction in view of poor general condition and comorbid illness. After v...

Full description

Bibliographic Details
Main Authors: Deepak Kumar Shukla, Satyendra Katewa, Ravikant Porwal, Ravi Dara, Lalit Sharma, Rahul Sharma, Aadesh Arora
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Leukemia Research Reports
Subjects:
AML
Unfit
Azacitidine
Venetoclax
Young
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048921000340

Similar Items

Similar Items